journal article·2019-03

A Highly Efficient Tumor‐Targeting Nanoprobe with a Novel Cell Membrane Permeability Mechanism

Zhendong Lei, Lin Ding, Chenjie Yao, Fengfeng Mo, Chenchen Li, Yanan Huang, Xuelian Yin, Min Li, Jinliang Liu, Yong Zhang, Changquan Ling, Yanli Wang

Advanced Materials· Volume 31· Issue 12
Publisher page

Abstract

Abstract Efficient tumor targeting has been a great challenge in the clinic for a very long time. The traditional targeting methods based on enhanced permeability and retention (EPR) effects show only an ≈5% targeting rate. To solve this problem, a new graphene‐based tumor cell nuclear targeting fluorescent nanoprobe (GTTN), with a new tumor‐targeting mechanism, is developed. GTTN is a graphene‐like single‐crystalline structure amphiphilic fluorescent probe with a periphery that is functionalized by sulfonic and hydroxyl groups. This probe has the characteristic of specific tumor cell targeting, as it can directly cross the cell membrane and specifically target to the tumor cell nucleus by the changed permeability of the tumor cell membranes in the tumor tissue. This new targeting mechanism is named the cell membrane permeability targeting (CMPT) mechanism, which is very different from the EPR effect. These probes can recognize tumor tissue at a very early stage and track the invasion and metastasis of tumor cells at the single cell level. The tumor‐targeting rate is improved from less than 5% to more than 50%. This achievement in efficient and accurate tumor cell targeting will speed up the arrival of a new era of tumor diagnosis and treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Nanochemistry and Nanobiology Shanghai University Shanghai 200444 P. R. China

Department of Biomedical Engineering National University of Singapore Singapore 119077 Singapore

Program in Molecular and Integrative Physiological Sciences Harvard T.H. Chan School of Public Health Harvard University Boston MA 02115 USA

Ship Hygiene Department Faculty of Naval Medicine Second Military Medical University Shanghai 200433 P. R. China

Department of Traditional Chinese Medicine Changhai Hospital The Second Military Medical University Shanghai 200433 P. R. China

Funding

National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1002/adma.20140011110.1002/adma.201400111 ↗
2. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
3. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
4. 10.1016/S1359-6349(10)70002-110.1016/S1359-6349(10)70002-1 ↗
5. 10.1016/j.jconrel.2014.12.01810.1016/j.jconrel.2014.12.018 ↗
6. 10.1016/j.jconrel.2016.11.01510.1016/j.jconrel.2016.11.015 ↗
7. 10.1016/j.addr.2016.04.02510.1016/j.addr.2016.04.025 ↗
8. 10.1016/j.jconrel.2012.07.01310.1016/j.jconrel.2012.07.013 ↗
9. 10.1016/j.nano.2015.07.01510.1016/j.nano.2015.07.015 ↗
10. 10.2165/00003088-200342050-0000210.2165/00003088-200342050-00002 ↗
11. 10.1517/14656566.3.12.173910.1517/14656566.3.12.1739 ↗
12. 10.1038/nmat387710.1038/nmat3877 ↗
13. 10.1038/nrd259110.1038/nrd2591 ↗
14. 10.1016/j.addr.2012.09.03810.1016/j.addr.2012.09.038 ↗
15. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
16. 10.1073/pnas.161689511310.1073/pnas.1616895113 ↗
17. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
18. 10.1073/pnas.050082210210.1073/pnas.0500822102 ↗
19. 10.1126/science.122633810.1126/science.1226338 ↗
20. 10.1038/nm.339410.1038/nm.3394 ↗
21. 10.1007/s11426-018-9397-510.1007/s11426-018-9397-5 ↗
22. 10.1038/ncomms635710.1038/ncomms6357 ↗
23. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
24. 10.1021/acsnano.5b0132010.1021/acsnano.5b01320 ↗
25. 10.1007/s00432-014-1767-310.1007/s00432-014-1767-3 ↗
26. 10.1021/acs.bioconjchem.7b0046610.1021/acs.bioconjchem.7b00466 ↗
27. 10.1038/nature2403510.1038/nature24035 ↗
28. 10.1016/j.jconrel.2011.06.00110.1016/j.jconrel.2011.06.001 ↗
29. 10.1016/j.nantod.2014.04.00810.1016/j.nantod.2014.04.008 ↗
30. 10.1021/acs.bioconjchem.6b0043710.1021/acs.bioconjchem.6b00437 ↗
31. 10.1016/j.jconrel.2012.03.02210.1016/j.jconrel.2012.03.022 ↗
32. Anghileri L. J. · J. Nucl. Med. · 1988 · 29 · 663
33. Abercrombie M. · Cancer Res. · 1962 · 22 · 525
34. 10.1073/pnas.61.3.86810.1073/pnas.61.3.868 ↗
35. 10.1016/j.foodcont.2014.05.05310.1016/j.foodcont.2014.05.053 ↗
36. 10.1089/bio.2015.007910.1089/bio.2015.0079 ↗
37. 10.1016/j.ecoenv.2016.03.03510.1016/j.ecoenv.2016.03.035 ↗
38. 10.1007/s00018-004-4424-110.1007/s00018-004-4424-1 ↗
39. 10.1038/nrclinonc.2014.5710.1038/nrclinonc.2014.57 ↗
40. 10.3109/0265673930902254210.3109/02656739309022542 ↗
41. 10.1093/icvts/ivx07910.1093/icvts/ivx079 ↗
42. 10.1038/nrc145610.1038/nrc1456 ↗
43. 10.1152/jappl.1977.42.2.14410.1152/jappl.1977.42.2.144 ↗
44. 10.1124/jpet.106.10971010.1124/jpet.106.109710 ↗
45. 10.1016/0005-2728(69)90096-610.1016/0005-2728(69)90096-6 ↗
46. 10.14348/molcells.2017.007510.14348/molcells.2017.0075 ↗
47. 10.3177/jnsv.56.34710.3177/jnsv.56.347 ↗
48. 10.1007/978-981-13-0502-3_1610.1007/978-981-13-0502-3_16 ↗
49. 10.1039/c2lc21174b10.1039/c2lc21174b ↗
50. 10.1021/ja401612x10.1021/ja401612x ↗
51. 10.3109/09687688.2010.51080410.3109/09687688.2010.510804 ↗
52. 10.1021/ja104317710.1021/ja1043177 ↗
53. 10.1021/acsnano.5b0132010.1021/acsnano.5b01320 ↗
54. 10.1016/j.biomaterials.2010.05.02710.1016/j.biomaterials.2010.05.027 ↗
55. 10.1097/00007890-199806150-0000710.1097/00007890-199806150-00007 ↗
56. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗